Clinical Trial
Vinblastine, cisplatin and bleomycin treatment of advanced nonseminomatous testicular tumors
Affiliations
- PMID: 1700311
Item in Clipboard
Clinical Trial
Vinblastine, cisplatin and bleomycin treatment of advanced nonseminomatous testicular tumors
Neoplasma.
1990.
Abstract
Between December 1979 and July 1986, 190 patients with nonseminomatous germ-cell testicular tumors were treated according to the modified Einhorn scheme. The response rate was 67.89%. The most favorable results were found in the embryonal histologic type (RR = 76.9%), in the biological marker (AFP, HCG) negative (RR = 97.43%) and in the minimal pulmonary extent group (RR = 94.12%).
Similar articles
-
Cisplatin containing combination chemotherapy of advanced germ cell line testicular tumours.Acta Med Hung. 1994;50(3-4):275-92. Acta Med Hung. 1994. PMID: 8587840 Clinical Trial.
-
Selected use of aggressive adjuvant chemotherapy in resected stage II nonseminomatous germ cell tumors of the testis.Prog Clin Biol Res. 1985;203:585-90. Prog Clin Biol Res. 1985. PMID: 2421344 No abstract available.
-
Treatment results of stage III germinal testicular tumors.Turk J Pediatr. 1984;26(1-4):301-6. Turk J Pediatr. 1984. PMID: 6085662 No abstract available.
-
Late relapse of nonseminomatous germ cell tumor of the testis: successful treatment with salvage chemotherapy alone.Urology. 1997 Mar;49(3):469-70. doi: 10.1016/S0090-4295(96)00495-5. Urology. 1997. PMID: 9123720 Review.
-
Long-term results following adjuvant chemotherapy in patients with clinical stage I testicular nonseminomatous malignant germ cell tumors with high risk factors.J Urol. 1999 Apr;161(4):1148-52. J Urol. 1999. PMID: 10081858 Review.
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Medical